Multiple Sources of Contamination in Samples from Patients Reported to Have XMRV Infection

• Mary F. Kearney ,

  * E-mail: kearneym@mail.nih.gov

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Jonathan Spindler,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Ann Wiegand,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Wei Shao,

  Affiliation Advanced Biomedical Computing Center, SAIC, Frederick, Maryland, United States of America

  ⨯
• Elizabeth M. Anderson,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Frank Maldarelli,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Francis W. Ruscetti,

  Affiliation Laboratory of Experimental Immunology, Cancer and Inflammation Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• John W. Mellors,

  Affiliation Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Steve H. Hughes,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Stuart F. J. Le Grice,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• John M. Coffin

  Affiliation Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, United States of America

  ⨯